These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7343249)

  • 21. Safety & efficacy of Japanese encephalitis vaccine produced in India.
    Rao Bhau LN; Singh G; Gowal D; Saxena SN; Kobayashi M; Oya A; Yoshioka I
    Indian J Med Res; 1988 Oct; 88():301-7. PubMed ID: 2852169
    [No Abstract]   [Full Text] [Related]  

  • 22. Japanese encephalitis vaccine and adverse effects among travellers.
    Robinson HC; Russell ML; Csokonay WM
    Can Dis Wkly Rep; 1991 Aug; 17(32):173-4, 177. PubMed ID: 1657420
    [No Abstract]   [Full Text] [Related]  

  • 23. Japanese encephalitis vaccination, with reference to travellers to Seoul, Korea.
    Can Dis Wkly Rep; 1988 Sep; 14(36):161-2. PubMed ID: 2852545
    [No Abstract]   [Full Text] [Related]  

  • 24. [Analysis on the immuno-effects of two different Japanese encephalitis virus vaccines].
    Guo W; Li L; Wu Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Apr; 19(2):97-9. PubMed ID: 10322719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutralization antibody responses induced by Japanese encephalitis virus vaccine.
    Susilowati S; Okuno Y; Fukunaga T; Tadano M; Juang RF; Fukai K
    Biken J; 1981 Dec; 24(4):137-45. PubMed ID: 7346039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Studies on immune response of attenuated Japanese encephalitis vaccine virus strain].
    Chen BQ; Tignor CH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Dec; 5(6):378-81. PubMed ID: 6233022
    [No Abstract]   [Full Text] [Related]  

  • 27. Mucosal vaccination approach against mosquito-borne Japanese encephalitis virus.
    Harakuni T; Kohama H; Tadano M; Uechi G; Tsuji N; Matsumoto Y; Miyata T; Tsuboi T; Oku H; Arakawa T
    Jpn J Infect Dis; 2009 Jan; 62(1):37-45. PubMed ID: 19168957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antibody response following Japanese encephalitis vaccination in patients undergoing maintenance hemodialysis].
    Nakamura Y; Matsubara H; Yoshioka S; Sumimoto R; Tabe Y; Fukuda M; Eto T; Dohi K; Yasuda K
    Nihon Jinzo Gakkai Shi; 1985 Jun; 27(6):839-44. PubMed ID: 4079116
    [No Abstract]   [Full Text] [Related]  

  • 29. Certain characteristics of Japanese encephalitis virus strains by neutralization test.
    Banerjee K
    Indian J Med Res; 1986 Mar; 83():243-50. PubMed ID: 3733180
    [No Abstract]   [Full Text] [Related]  

  • 30. [Which vaccines for which travelers?].
    Louis FJ; Morillon M; Martet G
    Med Trop (Mars); 1997; 57(1):27-30. PubMed ID: 9289603
    [No Abstract]   [Full Text] [Related]  

  • 31. Potency testing of inactivated tissue culture vaccine against Japanese encephalitis using antigen capture ELISA.
    Joshi AM; Walimbe AM; Banerjee K
    Acta Virol; 1997 Jun; 41(3):157-9. PubMed ID: 9385404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence of the partial effects of inactivated Japanese encephalitis vaccination: analysis of previous outbreaks in Japan from 1953 to 1960.
    Satou K; Nishiura H
    Ann Epidemiol; 2007 Apr; 17(4):271-7. PubMed ID: 17300956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled Phase 3 study.
    Schuller E; Klade CS; Wölfl G; Kaltenböck A; Dewasthaly S; Tauber E
    Vaccine; 2009 Mar; 27(15):2188-93. PubMed ID: 19200452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of in vitro correlate of cell mediated immunity following Japanese encephalitis inactivated vaccine among laboratory personnel.
    Kelkar SD; Rodrigues FM; Banerjee K
    Indian J Med Res; 1986 Jan; 83():104-7. PubMed ID: 3699863
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure of Japanese encephalitis vaccine and infection in inducing neutralizing antibodies against West Nile virus, People's Republic of China.
    Tang F; Zhang JS; Liu W; Zhao QM; Zhang F; Wu XM; Yang H; Ly H; Cao WC
    Am J Trop Med Hyg; 2008 Jun; 78(6):999-1001. PubMed ID: 18541783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China.
    Ding D; Kilgore PE; Clemens JD; Wei L; Zhi-Yi X
    Bull World Health Organ; 2003; 81(5):334-42. PubMed ID: 12856051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The influence of the season of birth on preventive efficacy of the Japanese encephalitis vaccine (author's transl)].
    Miura T; Tamura H; Shimura M
    Nihon Eiseigaku Zasshi; 1976 Oct; 31(4):520-4. PubMed ID: 190430
    [No Abstract]   [Full Text] [Related]  

  • 39. Diminished response to tick-borne encephalitis vaccination in thymectomized children.
    Prelog M; Wilk C; Keller M; Karall T; Orth D; Geiger R; Walder G; Laufer G; Cottogni M; Zimmerhackl Lothar B; Stein J; Grubeck-Loebenstein B; Wuerzner R
    Vaccine; 2008 Jan; 26(5):595-600. PubMed ID: 18178293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection.
    Pugachev KV; Mason PW; Shope RE; Frey TK
    Virology; 1995 Oct; 212(2):587-94. PubMed ID: 7571428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.